Top-Rated StocksTop-RatedNASDAQ:STTK Shattuck Labs (STTK) Stock Price, News & Analysis $6.09 -0.22 (-3.42%) As of 03:34 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Shattuck Labs Stock (NASDAQ:STTK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Shattuck Labs alerts:Sign Up Key Stats Today's Range$6.06▼$6.3950-Day Range$5.85▼$8.0652-Week Range$1.70▼$8.33Volume429,975 shsAverage Volume930,279 shsMarket Capitalization$611.59 millionP/E RatioN/ADividend YieldN/APrice Target$12.78Consensus RatingBuy Company Overview Shattuck Labs, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for cancer and other serious diseases. The company’s research is based on its Agonist Redirected Checkpoint (ARC) platform, which is designed to create bifunctional fusion proteins that combine immune-cell activation with the targeted blocking of immune-suppressive pathways. Shattuck’s lead investigational programs are intended to stimulate antitumor immune responses within the tumor microenvironment. Its pipeline has included ARC therapeutics designed to combine CD40 agonism with checkpoint inhibition, including SL-172154, which has been evaluated in clinical studies involving patients with advanced solid tumors. These products remain investigational and have not been approved for commercial use. Founded in 2016 and headquartered in Austin, Texas, Shattuck Labs has advanced its programs through early-stage clinical development and collaborations with research and medical institutions. The company is led by President and Chief Executive Officer Taylor Schreiber, M.D., Ph.D. Shattuck’s shares trade on the Nasdaq under the symbol STTK.AI Generated. May Contain Errors. Read More Shattuck Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreSTTK MarketRank™: Shattuck Labs scored higher than 59% of companies evaluated by MarketBeat, and ranked 382nd out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingShattuck Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 9 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialShattuck Labs has a consensus price target of $12.78, representing about 107.4% upside from its current price of $6.16.Amount of Analyst CoverageShattuck Labs has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Shattuck Labs' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Shattuck Labs are expected to decrease in the coming year, from ($0.45) to ($0.49) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shattuck Labs is -12.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Shattuck Labs is -12.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioShattuck Labs has a P/B Ratio of 4.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Shattuck Labs' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.44% of the float of Shattuck Labs has been sold short.Short Interest Ratio / Days to CoverShattuck Labs has a short interest ratio ("days to cover") of 8.38.Change versus previous monthShort interest in Shattuck Labs has recently increased by 22.21%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldShattuck Labs does not currently pay a dividend.Dividend GrowthShattuck Labs does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.60 News SentimentShattuck Labs has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Shattuck Labs this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for STTK on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat Follows3 people have added Shattuck Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Shattuck Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $379,305.00 in company stock.Percentage Held by Insiders8.79% of the stock of Shattuck Labs is held by insiders.Percentage Held by Institutions58.74% of the stock of Shattuck Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Shattuck Labs' insider trading history. Receive STTK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shattuck Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STTK Stock News HeadlinesShattuck Labs, Inc.(NasdaqGS:STTK) added to S&P Biotechnology Select Industry IndexSeptember 21, 2026 | marketscreener.comMContrasting Shattuck Labs (NASDAQ:STTK) and AnaptysBio (NASDAQ:ANAB)September 20, 2026 | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.September 25 at 1:00 AM | Stansberry Research (Ad)Shattuck Labs Announces Participation in Upcoming September Investor ConferencesSeptember 2, 2026 | globenewswire.comShattuck Labs: A Receptor-Side Bet On The TL1A BoomSeptember 1, 2026 | seekingalpha.comShattuck Labs Advances SL-325 Crohn’s Trial Toward a Key Value MilestoneAugust 12, 2026 | tipranks.comShattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business HighlightsAugust 11, 2026 | markets.businessinsider.comShattuck Labs Reports Positive Phase 1 Data for SL-325 and Advances DR3 Pipeline with Phase 2b Crohn’s Study Planned for 2026August 11, 2026 | quiverquant.comQSee More Headlines STTK Stock Analysis - Frequently Asked Questions How have STTK shares performed this year? Shattuck Labs' stock was trading at $3.65 at the beginning of the year. Since then, STTK shares have increased by 68.8% and is now trading at $6.16. How were Shattuck Labs' earnings last quarter? Shattuck Labs, Inc. (NASDAQ:STTK) released its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.00. When did Shattuck Labs IPO? Shattuck Labs (STTK) raised $178 million in an initial public offering (IPO) on Friday, October 9th 2020. The company issued 11,882,352 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and Evercore ISI served as the underwriters for the IPO and Needham & Co. was co-manager. Who are Shattuck Labs' major shareholders? Top institutional shareholders of Shattuck Labs include BlackRock Inc. (5.13%), Frazier Life Sciences Management L.P. (3.74%), Wellington Management Group LLP (2.31%) and S&G Foundation (0.57%). Insiders that own company stock include Redmile Group, Llc, Orbimed Advisors Llc, Mona Ashiya, Clay B Siegall, Tyler Brous, Andrew R Neill, Arundathy N Pandite, Abhinav A Shukla, Stephen Stout and Taylor Schreiber. View institutional ownership trends. How do I buy shares of Shattuck Labs? Shares of STTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Shattuck Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shattuck Labs investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR S&P 500 ETF Trust (SPY), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/11/2026Today9/25/2026Next Earnings (Estimated)11/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 STTK's financial health is in the Green zone, according to TradeSmith. STTK has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:STTK CIK1680367 Webwww.shattucklabs.com Phone512-900-4690FaxN/AEmployees40Year Founded2016Price Target and Rating Average Price Target for Shattuck Labs$12.78 High Price Target$18.00 Low Price Target$7.00 Potential Upside/Downside+108.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$48.81 million Net MarginsN/A Pretax Margin-5,256.80% Return on Equity-43.57% Return on Assets-40.90% Debt Debt-to-Equity RatioN/A Current Ratio27.59 Quick Ratio27.59 Sales & Book Value Annual Sales$1 million Price / Sales614.20 Cash FlowN/A Price / Cash FlowN/A Book Value$1.30 per share Price / Book4.71Miscellaneous Outstanding Shares100,360,000Free Float91,541,000Market Cap$614.20 million OptionableOptionable Beta1.09 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:STTK) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
